The Public Record
James Richardson Comer is an American politician serving as the U.S. Representative for Kentucky's 1st congressional district since January 3, 2016. A member of the Republican Party, Comer has focused on issues such as agriculture, economic development, and government accountability during his tenure. He previously served as the Kentucky Commissioner of Agriculture from 2012 to 2016, where he worked on various initiatives to support farmers and promote the state's agricultural products.
For purposes of debate only, I yield the customary 30 minutes to the gentleman from Maryland (Mr. Raskin), the ranking member of the House Committee on Oversight and Accountability, pending which I yield myself such time as I may consume…
Today's hearing will shine a bright light on President Biden's whole-of-government regulatory blitz that began on his first day in office.
Joe Biden has issued more than $200 billion in new regulations in his first year in office.
What a noble concept, putting the power of regulation in the hands of Congress.
I think we know that there are some folks who are very clever and creative in how they do this work. Middlemen have always skimmed money off the top, and it is a matter of how we can try to keep the resources where they are most needed…
If we are going to have a serious conversation about reducing drug costs in America, and we do not mention the PBM, then no one is serious about reducing drug costs.
There is 100 percent agreement, and 100 percent bipartisan support to act on these PBM's.
What are they hiding? Why are they afraid to come and answer questions about one of its own priorities?
The Biden Administration does not seem to understand it is supposed to be government of, by, and for the people.
Under his watch energy prices have skyrocketed, while agencies push through rules to suppress energy production.
What are they hiding? Why is it--why are they afraid to come and answer questions?
The Biden Administration is looking to regulate gas stoves out of existence.
I think that we can work together, Mr. Ranking Member, not just our Members, but our staff on trying to come up with a bipartisan solution.
I am not defending the pharmaceutical companies, but there is a difference between the pharmaceutical companies and the PBMs.
An identical prescription, a 30-day supply of imatinib would only cost $72 at Cost Plus Drugs. That is a massive difference.
I think it is long overdue that the FDA explained to us why we continue to have a problem with supply chain.
We do not even know when a drug shortage is going to happen, and as a result of which we cannot address it because it catches us off guard.
Politicians like James Comer
